Literature DB >> 11431009

Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages.

Z G Jiang1, C Piggee, M P Heyes, C Murphy, B Quearry, M Bauer, J Zheng, H E Gendelman, S P Markey.   

Abstract

We sought to identify neurotoxin(s) secreted by HIV-1-infected mononuclear phagocytes that could contribute to the pathophysiology of HIV-1-associated dementia (HAD). Neurotoxic factors were characterized in batches of conditioned media (CM) from human monocyte-derived macrophages (MDM) infected with HIV-1(ADA) and/or activated with lipopolysaccharide (LPS). All of the neurotoxicity was: present in the <3000-Da fraction; blocked by 5 microM MK801; and not trypsin sensitive or extractable into polar organic solvents. Glutamate measured in CM accounted for all neurotoxic effects observed from HIV/LPS CM in astrocyte-poor neuronal cultures and may contribute to the pathophysiology of HIV-1-associated dementia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431009     DOI: 10.1016/s0165-5728(01)00315-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  66 in total

1.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

2.  SIV-Induced Immune Activation and Metabolic Alterations in the Dorsal Root Ganglia During Acute Infection.

Authors:  Lisa M Mangus; Rachel L Weinberg; Audrey C Knight; Suzanne E Queen; Robert J Adams; Joseph L Mankowski
Journal:  J Neuropathol Exp Neurol       Date:  2019-01-01       Impact factor: 3.685

3.  HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism.

Authors:  Kelly A Krogh; Elizabeth Lyddon; Stanley A Thayer
Journal:  J Neurochem       Date:  2014-09-18       Impact factor: 5.372

Review 4.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 5.  Debate: "is increasing neuroinflammation beneficial for neural repair?".

Authors:  Keith A Crutcher; Howard E Gendelman; Jonathan Kipnis; J Regino Perez-Polo; V H Perry; Phillip G Popovich; Lynne C Weaver
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-23       Impact factor: 4.147

6.  Neuroinflammation in treated HIV-positive individuals: A TSPO PET study.

Authors:  Jaime H Vera; Qi Guo; James H Cole; Adriano Boasso; Louise Greathead; Peter Kelleher; Eugenii A Rabiner; Nicola Kalk; Courtney Bishop; Roger N Gunn; Paul M Matthews; Alan Winston
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

7.  Glutaminase dysregulation in HIV-1-infected human microglia mediates neurotoxicity: relevant to HIV-1-associated neurocognitive disorders.

Authors:  Yunlong Huang; Lixia Zhao; Beibei Jia; Li Wu; Yuju Li; Norman Curthoys; Jialin C Zheng
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

8.  Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter.

Authors:  Kalpana J Kallianpur; Cecilia Shikuma; Gregory R Kirk; Bruce Shiramizu; Victor Valcour; Dominic Chow; Scott Souza; Beau Nakamoto; Napapon Sailasuta
Journal:  Neurology       Date:  2013-04-17       Impact factor: 9.910

9.  Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr.

Authors:  Prasun K Datta; Satish Deshmane; Kamel Khalili; Salim Merali; John C Gordon; Chiara Fecchio; Carlos A Barrero
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

10.  Nitrated alpha-synuclein and microglial neuroregulatory activities.

Authors:  Ashley D Reynolds; Irena Kadiu; Sanjay K Garg; Jason G Glanzer; Tara Nordgren; Pawel Ciborowski; Ruma Banerjee; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2008-01-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.